| Page 1436 | Kisaco Research
 

Romaine Daillere

Co-Founder & Head of Preclinical Research
Everimmune

Romain Daillère completed his PhD in 2015 in the laboratory of Professor Laurence Zitvogel at the Gustave Roussy Cancer Campus (GRCC), Villejuif-Grand Paris/France. His research focuses on the complex interplay between gut microbiota and the efficacy of anticancer regimens. He previously graduated as a biotechnology engineer at the Ecole Supérieure de Biotechnology de Strasbourg (Trinational School of Strasbourg), and worked at the Ragon Institute of MIT, MGH and Harvard in Boston. Co-founder of EverImmune. Co-Inventor of EverImmune Technology.

Romaine Daillere

Co-Founder & Head of Preclinical Research
Everimmune

Romaine Daillere

Co-Founder & Head of Preclinical Research
Everimmune

Romain Daillère completed his PhD in 2015 in the laboratory of Professor Laurence Zitvogel at the Gustave Roussy Cancer Campus (GRCC), Villejuif-Grand Paris/France. His research focuses on the complex interplay between gut microbiota and the efficacy of anticancer regimens. He previously graduated as a biotechnology engineer at the Ecole Supérieure de Biotechnology de Strasbourg (Trinational School of Strasbourg), and worked at the Ragon Institute of MIT, MGH and Harvard in Boston. Co-founder of EverImmune. Co-Inventor of EverImmune Technology. He currently acts as head of the preclinical research of EverImmune.

 

Rochellys Diaz Heijtz

Associate Professor
Karolinska Institute

Rochellys Diaz Heijtz

Associate Professor
Karolinska Institute

Rochellys Diaz Heijtz

Associate Professor
Karolinska Institute
 

John Weinberg

Chief Medical Officer
MaaT Pharma

John Weinberg

Chief Medical Officer
MaaT Pharma

John Weinberg

Chief Medical Officer
MaaT Pharma
 

Denise Kelly

Consultant
Seventure

Denise Kelly

Consultant
Seventure

Denise Kelly

Consultant
Seventure
 

Anita Patel Jusnes

Chief Commercial Officer
Genetic Analysis

Anita Patel Jusnes

Chief Commercial Officer
Genetic Analysis

Anita Patel Jusnes

Chief Commercial Officer
Genetic Analysis
 

Aaron Anselmo

Assistant Professor
The University of North Carolina at Chapel Hill

Aaron Anselmo

Assistant Professor
The University of North Carolina at Chapel Hill

Aaron Anselmo

Assistant Professor
The University of North Carolina at Chapel Hill
 
Microbiome Connect: Skin EU 2021
7-9 Dec 2021
VIRTUAL EVENT
With key CPG brands launching skin microbiome focused brands over the last few years, skin microbiome is entering the mainstream of the beauty and personal care industry. The field is still in a nascent stage, but as next generation sequencing techniques and big data analysis improve, a galaxy of new information is set to be uncovered. With new regulation coming in to hold back the use of unsubstantiated claims, with high profile cases including Clariant, understanding the research and governing of this space has never been more important.Join us this December to find out about the latest R&D and regulation that is shaping the direction for skin microbiome product development with our expert speaker faculty of key industry representatives and academics."An amazing event, bringing you close to industrial representatives and providing you with the opportunity to not only understand what companies are doing but also to talk with them in engage in discussion. What a great networking opportunity" - KU Leuven
 

Shai Ufaz

CEO and Co-Founder
ViAqua Therapeutics

Shai Ufaz brings over 15 years of experience in biotechnology and molecular biology project management.  Prior to establishing ViAqua, Shai served as project manager at Protalix Biotherapeutics, a biotechnology pharmaceutical company and as Team leader at TransAlgae, an algae-based biotech startup. Shai holds a Ph.D. in plant biotechnology from Tel Aviv University and a postdoctoral fellow from the Weizmann Institute of Science.

Shai Ufaz

CEO and Co-Founder
ViAqua Therapeutics

Shai Ufaz

CEO and Co-Founder
ViAqua Therapeutics

Shai Ufaz brings over 15 years of experience in biotechnology and molecular biology project management.  Prior to establishing ViAqua, Shai served as project manager at Protalix Biotherapeutics, a biotechnology pharmaceutical company and as Team leader at TransAlgae, an algae-based biotech startup. Shai holds a Ph.D. in plant biotechnology from Tel Aviv University and a postdoctoral fellow from the Weizmann Institute of Science.

 

Nils Arne Grønlie

General Manager
PHARMAQ

As General Manager of PHARMAQ Analytiq Nils Arne leads highly talented teams of aquaculture specialists who safeguard fish health and welfare by using advanced detection and diagnostics methods to create value for our customers. Nils Arne has also worked as Senior Director of Operations in PHARMAQ AS, coordinating various functions of the aquaculture business across functions and geographies, including global product supply activities, EHS, BCP, and IPR.

Nils Arne Grønlie

General Manager
PHARMAQ

Nils Arne Grønlie

General Manager
PHARMAQ

As General Manager of PHARMAQ Analytiq Nils Arne leads highly talented teams of aquaculture specialists who safeguard fish health and welfare by using advanced detection and diagnostics methods to create value for our customers. Nils Arne has also worked as Senior Director of Operations in PHARMAQ AS, coordinating various functions of the aquaculture business across functions and geographies, including global product supply activities, EHS, BCP, and IPR.

 

Dmitry Kozachenok

CEO
Ecto

Dmitry Kozachenok

CEO
Ecto

Dmitry Kozachenok

CEO
Ecto